世界の動物/獣医ワクチン市場...市場調査レポートについてご紹介

Table Of Contents

1 Introduction (Page No. – 22)
1.1 Key Take-Aways
1.2 Report Description
1.3 Research Methodology
1.3.1 Market Size Estimation
1.3.2 Market Share
1.3.3 Key Data Points From Secondary Sources
1.3.4 Key Data Points From Primary Sources
1.3.5 Assumptions
1.4 Markets Covered
1.5 Stakeholders
1.6 Market Scope

2 Executive Summary (Page No. – 33)

3 Market Overview (Page No. – 37)
3.1 Introduction
3.2 Market Segmentation
3.3 Market Dynamics
3.3.1 Drivers
3.3.1.1 Growing Prevalence Of Animal Diseases Will Result In Employing Preventive Measures Like Vaccines
3.3.1.2 Increasing Incidences Of Zoonotic Diseases In Humans Will Propel The Vaccines Market
3.3.1.3 Increasing Investments By Various Government Agencies, Animal Associations, & Leading Players To Propel The Market
3.3.1.4 Continuous Innovations & Introduction Of New Products Propels The Market
3.3.2 Restraints
3.3.2.1 Rising Maintenance Costs For Storage Of Vaccines, A Burden On Manufacturers & Distributors
3.3.2.2 Increasing Adoption Of Vegetarian Food In Major Economies Owing To Increasing Risk Of Obesity And Other Chronic Disorders
3.3.2.3 Persistent Economic Slowdown To Affect Growth
3.3.3 Opportunities
3.3.3.1 Technological Innovations Like Dna Vaccines
3.3.3.2 Growing Awareness Of Animal Health In Emerging Economies
3.3.3.3 Increasing Investment Opportunities In Emerging And Immature Markets
3.4 Regulations For Animal Vaccines
3.4.1 Usda Regulates The Registration Process In U.S.
3.4.2 Emea Is The Apex Body For Approval Of Animal Vaccines In Europe
3.4.3 Maff Regulates The Veterinary Medicinal Products (VMPS) In Japan
3.4.4 Vich Harmonizes The Registration Process In U.S., Europe And Japan
3.5 Porter’s Five Forces Analysis
3.5.1 Threat From New Entrants
3.5.2 Threat From Substitutes
3.5.3 Bargaining Power Of Buyers
3.5.4 Bargaining Power Of Suppliers
3.5.5 Competitive Rivalry Among Existing Players
3.6 Market Share Analysis of Animal Vaccines
3.6.1 Global
3.6.2 North America
3.6.3 Europe
3.6.4 Asia

4 Global Market, By Product (Page No. – 58)
4.1 Introduction
4.2 Companion Animal Vaccines
4.2.1 Canine Vaccines Contribute The Largest To The Companion Animal Vaccines Market
4.2.2 Canine
4.2.3 Feline
4.3 Livestock
4.3.1 Increasing Investments By Government Bodies And Companies
4.3.2 Bovine
4.3.3 Small Ruminant
4.4 Poultry
4.5 Porcine
4.6 Equine
4.7 Aquaculture
4.7.1 Aquaculture Vaccines Market To Grow At The Fastest Pace
4.8 Other Animal Vaccines

5 Global Market, By Disease (Page No. – 72)
5.1 Introduction
5.2 Companion Animal Vaccines
5.2.1 Canine Vaccines, By Disease
5.2.1.1 Canine Rabies
5.2.1.2 Canine Distemper
5.2.1.3 Canine Parvovirus
5.2.1.4 Infectious Canine Hepatitis
5.2.2 Feline Vaccines, By Disease
5.2.2.1 Feline Rabies
5.2.2.2 Feline Panleukopenia
5.2.2.3 Feline Viral Rhinotracheitis
5.2.2.4 Feline Leukemia
5.3 Livestock Vaccines
5.3.1 Bovine Vaccines, By Disease
5.3.1.1 Foot And Mouth Disease (FMD)
5.3.1.2 Bovine Viral Diarrhea
5.3.1.3 Bovine Clostridial Diseases
5.3.1.4 Brucellosis
5.3.1.5 Infectious Bovine Rhinotracheitis
5.3.2 Small Ruminant Vaccines, By Disease
5.3.2.1 Small Ruminant Clostridial Diseases
5.3.2.2 Scabby Mouth Infection
5.3.2.3 Pneumonia & Septicemia
5.3.2.4 Pox Diseases
5.3.2.5 Ovine Johne’s Disease (Paratuberculosis)
5.4 Poultry Vaccines, By Disease
5.4.1 Infectious Bronchitis
5.4.2 Gumboro Disease
5.4.3 Avian Influenza
5.4.4 Coccidiosis
5.4.5 Marek’s Disease
5.4.6 Newcastle Disease
5.5 Porcine Vaccines, By Disease
5.5.1 Porcine Parvovirus
5.5.2 Porcine Reproductive Respiratory Syndrome (PRRS)
5.5.3 Porcine Circovirus Ii
5.5.4 Swine Influenza
5.5.5 Swine Pneumonia
5.6 Equine Vaccines, By Disease
5.6.1 Equine Encephalomyelitis
5.6.2 Strangles
5.6.3 Equine Influenza (Horse Flu)
5.6.4 Equine Rhinopneumonitis
5.7 Aquaculture Vaccines, By Disease
5.7.1 Vibriosis
5.7.2 Pasteurellosis
5.7.3 Furunculosis

6 Market – By Technology (Page No. – 108)
6.1 Introduction
6.2 Live Attenuated Vaccines (LAV)
6.3 Inactivated Vaccines
6.4 Subunit Vaccines
6.5 Toxoid Vaccines
6.6 Conjugate Vaccines
6.7 Recombinant Vaccines
6.8 Dna Vaccines
6.9 Live Attenuated Technology Contributes The Largest To The Livestock Vaccines Market
6.10 Dna Vaccines Along With Inactivated & Recombinant Technology To Grow At Healthy Pace
6.11 Inactivated Vaccines Technology Accounts For The Largest Share In Porcine Vaccine Market

7 Geographic Analysis (Page No. – 121)
7.1 Introduction
7.2 Europe
7.2.1 Europe Dominates The Animal Vaccine Market Owing To Highly Organized Livestock Sector
7.3 North America
7.3.1 Rise In Companion & Farm Animals To Drive The North American Market
7.3.2 Increase In Investments By Companies In North America
7.4 Asia
7.4.1 Asian Countries Offer Huge Opportunities To Vaccine Manufacturers
7.5 Rest Of The World (ROW)

8 Competitive Landscape (Page No. – 196)
8.1 Introduction
8.1.1 More Than 20 New Products Were Launched Between 2012 & 2013
8.2 Mergers & Acquisitions
8.3 Agreements, Partnerships, Collaborations, & Joint Ventures
8.4 New Product Launch
8.5 Other Developments

9 Company Profiles (Overview, Financials, Products & Services, Strategy, & Developments)* (Page No. – 210)
9.1 Bayer Healthcare
9.2 Biogenesis Bago S.A.
9.3 Bioniche Animal Health Canada, Inc.
9.4 Boehringer Ingelheim
9.5 Ceva (Ceva Sante Animale)
9.6 Heska Corporation
9.7 Indian Immunologicals Ltd.
9.8 Lohmann Animal Health International
9.9 Merck
9.10 Merial (Animal Health Division Of Sanofi)
9.11 Novartis Animal Health, Inc.
9.12 Protein Sciences Corporation
9.13 Virbac
9.14 Zoetis (Pfizer Animal Health) *Details On Financials, Product & Services, Strategy, & Developments Might Not Be Captured In Case Of Unlisted Companies.